NASDAQ
INNOCAN PHARMA Corp (INNPF) has a current ratio of 7.70x as of Tuesday, May 26, 2026. This represents a 56.50% increase compared to its 12-month average of 4.92x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.